Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Shares Outstanding (Diluted Average) (2022 - 2024)

CervoMed's Shares Outstanding (Diluted Average) history spans 4 years, with the latest figure at $12.2 million for Q3 2014.

  • For Q3 2014, Shares Outstanding (Diluted Average) rose 193.32% year-over-year to $12.2 million; the TTM value through Sep 2014 reached $12.2 million, up 193.32%, while the annual FY2013 figure was $2.6 million, 135.89% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q3 2014 was $12.2 million at CervoMed, up from $9.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $117.9 million in Q2 2012 and bottomed at $1.1 million in Q4 2012.
  • The 4-year median for Shares Outstanding (Diluted Average) is $7.7 million (2014), against an average of $40.4 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) plummeted 98.9% in 2013 before it surged 391.45% in 2014.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $101.0 million in 2011, then plummeted by 98.89% to $1.1 million in 2012, then soared by 135.89% to $2.6 million in 2013, then soared by 359.27% to $12.2 million in 2014.
  • Per Business Quant, the three most recent readings for CRVO's Shares Outstanding (Diluted Average) are $12.2 million (Q3 2014), $9.5 million (Q2 2014), and $5.9 million (Q1 2014).